Peyronie's Disease: Nonsurgical Therapy Options
Abstract
Peyronie's disease (PD) is a fibrous inelastic scar of the tunica albuginea, leading to penile deformity, penile curvature, shortening, narrowing, and painful erections that subsequently lead to painful or unsatisfying sexual intercourse. No consensus exists yet on the ideal management of PD. This fact is a result of our limited knowledge of its etiology and causative factors. The acute presentation of PD is treated conservatively, and surgical approaches are only attempted if severe curvature, narrowing, or indentation persists for more than 1 year; PD stability exists for at least 3 months; curvature impedes sexual intercourse; and severe penile shortening occurs. This review focuses on new developments for conservative treatment strategies for PD.
Keywords: Extracorporeal shock wave therapy; Intralesional therapy; Iontophoresis; Nonsurgical therapy; Oral medication; Penile traction systems; Peyronie’s disease.
Similar articles
-
Review of Management Options for Patients With Atypical Peyronie's Disease.Sex Med Rev. 2017 Apr;5(2):211-221. doi: 10.1016/j.sxmr.2016.07.004. Epub 2016 Aug 17. Sex Med Rev. 2017. PMID: 27544298 Review.
-
Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic "rationale" and related emerging treatment strategies.Inflamm Allergy Drug Targets. 2012 Feb;11(1):48-57. doi: 10.2174/187152812798889321. Inflamm Allergy Drug Targets. 2012. PMID: 22309083 Review.
-
Management of Peyronie's disease--a review.World J Urol. 2001 Aug;19(4):244-50. World J Urol. 2001. PMID: 11550782 Review.
-
Management of Peyronie's disease - a review.World J Urol. 2001 Aug;19(4):244-250. doi: 10.1007/s003450100209. World J Urol. 2001. PMID: 28386796
-
US Imaging in Peyronie's Disease.J Clin Imaging Sci. 2012;2:63. doi: 10.4103/2156-7514.103053. Epub 2012 Oct 31. J Clin Imaging Sci. 2012. PMID: 23230545 Free PMC article.
Cited by
-
Penile traction therapy for Peyronie's disease-what's the evidence?Transl Androl Urol. 2016 Jun;5(3):303-9. doi: 10.21037/tau.2016.03.25. Transl Androl Urol. 2016. PMID: 27298777 Free PMC article. Review.
-
Unveiling the molecular Hallmarks of Peyronie's disease: a comprehensive narrative review.Int J Impot Res. 2024 Dec;36(8):801-808. doi: 10.1038/s41443-024-00845-2. Epub 2024 Mar 7. Int J Impot Res. 2024. PMID: 38454161 Review.
-
Rationale of combination therapy with antioxidants in medical management of Peyronie's disease: results of clinical application.Res Rep Urol. 2017 Jul 20;9:129-139. doi: 10.2147/RRU.S141748. eCollection 2017. Res Rep Urol. 2017. PMID: 28791261 Free PMC article.
-
Recurrent Penile Fracture-Case Report and Alternative Surgical Approach.Sex Med. 2018 Sep;6(3):263-266. doi: 10.1016/j.esxm.2018.01.005. Epub 2018 May 3. Sex Med. 2018. PMID: 29731370 Free PMC article.
-
Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study.Res Rep Urol. 2015 Dec 31;8:1-10. doi: 10.2147/RRU.S97194. eCollection 2016. Res Rep Urol. 2015. PMID: 26770906 Free PMC article.
References
-
- Kendirci M, Hellstrom WJ. Critical analysis of surgery for Peyronie’s disease. Curr Opin Urol. 2004;14:381–388. - PubMed
-
- Devine CJ., Jr International Conference on Peyronie’s disease advances in basic and clinical research. March 17–19, 1993. Introduction. J Urol. 1997;157:272–275. - PubMed
-
- Smith BH. Subclinical Peyronie’s disease. Am J Clin Pathol. 1969;52:385–390. - PubMed
-
- Casabé A, Bechara A, Cheliz G, et al. Risk factors of Peyronie’s disease. What does our clinical experience show? J Sex Med. 2011;8:518–523. - PubMed
-
- Tunuguntla HS. Management of Peyronie’s disease-a review. World J Urol. 2001;19:244–250. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources